Seizing China opportunities via strategic outsourcing and corporate alliances

The landscape of drug discovery and development has changed dramatically over the past several years in efforts to address the significant hurdles in advancing new entities to the global market place. On one hand, companies face the challenge of maximising value-chain productivity and minimising costs and risks. On the other hand, companies need to maximise opportunities presented by rapidly-growing pharmaceutical markets and growing external innovation capabilities.